JP2017523225A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523225A5
JP2017523225A5 JP2017506964A JP2017506964A JP2017523225A5 JP 2017523225 A5 JP2017523225 A5 JP 2017523225A5 JP 2017506964 A JP2017506964 A JP 2017506964A JP 2017506964 A JP2017506964 A JP 2017506964A JP 2017523225 A5 JP2017523225 A5 JP 2017523225A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
carboxylic acid
formula
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017506964A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017523225A (ja
JP6577570B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/068257 external-priority patent/WO2016020526A1/en
Publication of JP2017523225A publication Critical patent/JP2017523225A/ja
Publication of JP2017523225A5 publication Critical patent/JP2017523225A5/ja
Application granted granted Critical
Publication of JP6577570B2 publication Critical patent/JP6577570B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017506964A 2014-08-08 2015-08-07 インフルエンザウイルス感染に使用するためのインドール類 Expired - Fee Related JP6577570B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14180331.2 2014-08-08
EP14180331 2014-08-08
PCT/EP2015/068257 WO2016020526A1 (en) 2014-08-08 2015-08-07 Indoles for use in influenza virus infection

Publications (3)

Publication Number Publication Date
JP2017523225A JP2017523225A (ja) 2017-08-17
JP2017523225A5 true JP2017523225A5 (enExample) 2019-08-22
JP6577570B2 JP6577570B2 (ja) 2019-09-18

Family

ID=51298610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506964A Expired - Fee Related JP6577570B2 (ja) 2014-08-08 2015-08-07 インフルエンザウイルス感染に使用するためのインドール類

Country Status (18)

Country Link
US (1) US10597390B2 (enExample)
EP (1) EP3177609A1 (enExample)
JP (1) JP6577570B2 (enExample)
KR (1) KR102488479B1 (enExample)
CN (1) CN106573920B (enExample)
AU (1) AU2015298876B2 (enExample)
BR (1) BR112017002370B1 (enExample)
CA (1) CA2954751C (enExample)
CL (1) CL2017000309A1 (enExample)
EA (1) EA201790266A1 (enExample)
IL (1) IL250408B (enExample)
MA (1) MA40547A (enExample)
MX (1) MX381488B (enExample)
PH (1) PH12017500207B1 (enExample)
SG (1) SG11201700956VA (enExample)
UA (1) UA124609C2 (enExample)
WO (1) WO2016020526A1 (enExample)
ZA (1) ZA201700952B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEAP202213376A (en) 2009-06-17 2022-02-25 Vertex Pharmaceuticals Incorporated Us Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
MA40547A (fr) 2014-08-08 2017-06-14 Janssen Sciences Ireland Uc Indoles pouvant être utilisés dans l'infection par le virus influenza
WO2016183116A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
JP6857617B2 (ja) 2015-05-13 2021-04-14 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated インフルエンザウイルスの複製の阻害剤
JP6952695B2 (ja) 2015-12-09 2021-10-20 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. インフルエンザウイルス複製の阻害剤、その適用方法および使用
KR20180099839A (ko) * 2016-01-07 2018-09-05 얀센 사이언시즈 아일랜드 유씨 인플루엔자 바이러스 감염에서 사용하기 위한 작용화된 펜탄산
WO2017133670A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza
WO2018033082A1 (en) * 2016-08-16 2018-02-22 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
WO2018041091A1 (en) * 2016-08-30 2018-03-08 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
KR102312088B1 (ko) * 2016-09-05 2021-10-14 광둥 레이노벤트 바이오테크 컴퍼니 리미티드 항인플루엔자 바이러스 피리미딘 유도체
EP3555095B1 (en) 2016-12-15 2023-04-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CA3047404A1 (en) * 2016-12-23 2018-06-28 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use
WO2018127096A1 (en) 2017-01-05 2018-07-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
US10927118B2 (en) 2017-03-02 2021-02-23 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CN108727369B (zh) * 2017-04-25 2023-06-09 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
CA3092315C (en) 2018-03-05 2023-08-29 Jian Xiong Crystal form and salt form of pyridopyrazole compound and preparation method therefor
EP3992192B1 (en) 2019-07-22 2026-02-18 Guangdong Raynovent Biotech Co., Ltd. Dominant salt forms of pyrimidine derivatives, and crystal forms thereof
CN113045475A (zh) * 2019-12-27 2021-06-29 上海泓博智源医药股份有限公司 一种5-溴-7-甲基吲哚的制备方法
AU2021313150A1 (en) * 2020-07-20 2023-03-16 Nido Biosciences, Inc. Indole compounds as androgen receptor modulators
US20240010643A1 (en) * 2020-09-18 2024-01-11 Sunshine Lake Pharma Co., Ltd. Preparation method of substituted pyrimidine piperazine compounds
AU2023361174A1 (en) * 2022-10-12 2025-05-01 Maze Therapeutics, Inc. Inhibitors of solute carrier family 6a member 19 (slc6a19) and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ584499A (en) 2004-03-30 2011-08-26 Vertex Pharma Azaindoles Useful as Inhibitors of Jak and Other Protein Kinases
AR060316A1 (es) 2006-01-17 2008-06-11 Vertex Pharma Azaindoles de utilidad como inhibidores de janus quinasas
GEAP202213376A (en) * 2009-06-17 2022-02-25 Vertex Pharmaceuticals Incorporated Us Inhibitors of influenza viruses replication
WO2012032065A1 (en) * 2010-09-08 2012-03-15 Glaxo Group Limited Indazole derivatives for use in the treatment of influenza virus infection
CN103492381A (zh) * 2010-12-16 2014-01-01 沃泰克斯药物股份有限公司 流感病毒复制的抑制剂
JP2013545818A (ja) * 2010-12-16 2013-12-26 バーテックス ファーマシューティカルズ インコーポレイテッド インフルエンザウイルス複製阻害物質
UA118010C2 (uk) * 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP2763990B1 (en) 2011-09-01 2017-02-22 F. Hoffmann-La Roche AG Pyrrolopyrazine kinase inhibitors
EP2858984A1 (en) * 2012-06-08 2015-04-15 Vertex Pharmaceuticals Inc. Inhibitors of influenza viruses replication
LT3068776T (lt) 2013-11-13 2019-08-12 Vertex Pharmaceuticals Incorporated Gripo virusų replikacijos inhibitoriai
MA40547A (fr) 2014-08-08 2017-06-14 Janssen Sciences Ireland Uc Indoles pouvant être utilisés dans l'infection par le virus influenza
UY36249A (es) 2014-08-08 2016-01-29 Bayer Cropscience Ag Compuestos sustituidos con halógeno novedosos
AR101448A1 (es) 2014-08-08 2016-12-21 Bayer Cropscience Ag Compuestos sustituidos por halógeno
CN104592038A (zh) 2015-01-12 2015-05-06 烟台万润精细化工股份有限公司 一种5,5-二甲基-1,3-环己二胺的制备方法

Similar Documents

Publication Publication Date Title
JP2017523225A5 (enExample)
JP2015024998A5 (enExample)
JP2020507589A5 (enExample)
JP2017531619A5 (enExample)
ZA202006378B (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
JP2019501879A5 (enExample)
JP2019509276A5 (enExample)
JP2020531422A5 (enExample)
HRP20211278T1 (hr) Supstituirani derivati indolina kao inhibitori replikacije denga virusa
JP2017531038A5 (enExample)
EA201992082A1 (ru) Ингибитор поверхностного антигена вируса гепатита b
JP2020532547A5 (enExample)
JP2019510034A5 (enExample)
JP2017517565A5 (enExample)
JP2017528503A5 (enExample)
JP2015537020A5 (enExample)
JP2019500387A5 (enExample)
JP2014511891A5 (enExample)
JP2013542247A5 (enExample)
JP2013543896A5 (enExample)
HRP20210038T1 (hr) Pirolopirimidini za uporabu u infekciji virusom gripe
JP2016540742A5 (enExample)
JP2016534063A5 (enExample)
JP2016510326A5 (enExample)
JP2015051983A5 (enExample)